newsfilter
← Latest News
GlobeNewswire·

CervoMed to Participate in H.C. Wainwright 3rd Annual BioConnect Investor Conference

BOSTON, May 07, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ:CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), today announced that